OPHTHALMOLOGY
Three-dimensional Enhanced Imaging of Vitreoretinal Interface in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography
The article “Three-dimensional Enhanced Imaging of Vitreoretinal Interface in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography” by Adhi and associates discusses the utility of swept-source optical coherence tomography (SSOCT) in…
A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004%
Purpose To evaluate the safety and efficacy of adding fixed-combination brinzolamide 1%/brimonidine 0.2% (BBFC) as adjunctive therapy to travoprost 0.004% (TRAV) in patients with open-angle glaucoma or ocular hypertension. Design…
Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study
Purpose To assess the effects of intravitreal bevacizumab injections in the treatment of nonsubfoveal choroidal neovascularization (CNV) associated with angioid streaks (AS) in a 3-year follow-up study. Design Noncomparative, interventional,…
Relating Retinal Morphology and Function in Aging and Early to Intermediate Age-related Macular Degeneration Subjects
Purpose To evaluate relationships between age-related macular degeneration (AMD) morphology on spectral-domain optical coherence tomography (SDOCT) and visual function. Design Cross-sectional, observational. Methods From the Alabama Study on Early AMD…
Swept-Source Optical Coherence Tomography Correlations Between Retina and Choroid Before and After Vitrectomy for Epiretinal Membranes
Purpose To describe retinal and choroidal morphology before and after surgery for epiretinal membranes (ERM) in swept-source OCT (SS-OCT). Additionally, to evaluate factors responsible for visibility of the suprachoroidal layer…
A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004%
Purpose To evaluate the safety and efficacy of adding fixed-combination brinzolamide 1%/brimonidine 0.2% (BBFC) as adjunctive therapy to travoprost 0.004% (TRAV) in patients with open-angle glaucoma or ocular hypertension. Design…
Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis
Purpose To determine the risk of second primary neoplasms (SPNs) in subjects previously diagnosed with uveal melanoma (UM), including an analysis on whether radiotherapy is a risk factor to develop…
Reporting Visual Acuities
The AJO encourages authors to report the visual acuity in the manuscript using the same nomenclature that was used in gathering the data provided they were recorded in one of…
The Blindness of King John
The direct responsibility a surgeon incurs when undertaking an operation was evident as early as the 14 th Century in the tale of the blindness of King John of Bohemia….
